Login to Your Account



MorphoSys Boosts Antibody Work With $35M Acquisition

By Jennifer Boggs


Friday, January 13, 2006
Expecting to triple the revenues from its research antibody division, MorphoSys AG is buying privately held Serotec Ltd. in a cash and stock deal valued at €29.3 million (US$35.3 million). (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription